Researcher
Steven De Vleeschouwer
- Disciplines:Biomechanics, Morphological sciences, Neurosciences, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Responsible
From1 Jan 2013 → Today - Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Member
From1 Aug 2001 → Today
Projects
1 - 10 of 22
- Molecular Brain Tumor DetectorFrom1 Feb 2024 → TodayFunding: Other EU initiatives out of framework
- The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomicsFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Immunotherapy for childhood, adolescent, and adult Glioblastoma: towards tumour-immune interactions driven precision medicine using spatially resolved radio-multiomics.From15 Jan 2023 → TodayFunding: BOF - various
- Investigating the role of astrocytes and noradrenaline as critical regulators of neuronal circuit excitability.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- De evidentie rond het coiling-clipping paradigma in de behandeling van cerebrale aneurysmata uitdagen en in kaart brengen door middel van multimodale stratificatie.From8 Dec 2021 → TodayFunding: FWO Strategic Basic Research Grant
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- Evaluating the Role of Autophagy in the Tumor Vasculature and as Anti-angiogenic Escape MechanismFrom1 Oct 2020 → 30 Sep 2021Funding: BOF - postdoctoral mandates
- Opening the brain blood barrier to treat brain tumoursFrom1 Jan 2020 → 31 Dec 2022Funding: H2020 - European Institute of Innovation and Technology, Horizon Europe - European Institute of Innovation and Technology (EIT)
- Screening of Hyp-PDT induced ICD-sensitive GBM Immunophenotype and Exploration of Synergetic Effect of Sonodynamic Therapy in GBM ImmunotherapyFrom2 Dec 2019 → 2 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Visual prostheses based on high resolution brain stimulationFrom1 Oct 2019 → 30 Sep 2023Funding: BOF - projects
Publications
111 - 120 of 141
- Galectin-1 Knockdown Enhances the Efficacy of Immunotherapy for Murine Malignant Glioma(2012)
Authors: Tina Verschuere, Jaan Toelen, Francoise Poirier, Wim Maes, Louis Boon, Veronique Mathieu, Florence Lefranc, Robert Kiss, Stefaan Van Gool, Steven De Vleeschouwer
Pages: 781 - 781 - STRATIFICATION ACCORDING TO HGG-IMMUNO RPA MODEL PREDICTS OUTCOME IN PATIENTS WITH RELAPSED MALIGNANT GLIOMA TREATED BY ADJUVANT POSTOPERATIVE DC VACCINATION(2012)
Authors: Steven De Vleeschouwer, Hilko Ardon, Frank Van Calenbergh, Raf Sciot, Guy Wilms, Johan van Loon, Jan Goffin, Stefaan Van Gool
Pages: 60 - 60 - Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?(2012)
Authors: Stefaan Van Gool, Steven De Vleeschouwer
Pages: 1173 - 1176 - Clinical study: Resection and Immunotherapy for Recurrent Grade III Glioma(2012)
Authors: Iris Elens, Steven De Vleeschouwer, Stefaan Van Gool
Pages: 1 - 9 - Hoe relevant is de simpsonclassificatie voor de kans op terugval van gereseceerde WHO graad I-meningioma's?(2012)
Authors: Steven De Vleeschouwer
Pages: 187 - 188 - MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study(2011)
Authors: Uwe Himmelreich, Stefaan Van Gool, Stefan Sunaert, Steven De Vleeschouwer, Philippe Demaerel
Pages: 721 - 731 - The dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)(2011)
Authors: Jan Ceuppens, Jan Goffin, Steven De Vleeschouwer
Pages: 612 - 614 - Galectin-1 and immunotherapy for brain cancer(2011)
Authors: Tina Verschuere, Steven De Vleeschouwer, Stefaan Van Gool
Pages: 533 - 543 - Long-lasting, complete exclusion of a large galnic dural arteriovenous fistula after clipping of the central venous aneurysm of the vein of galen: case report(2011)
Authors: Steven De Vleeschouwer, Guy Wilms
Pages: 571 - 574 - Het dysplastische cerebellair gangliocytoom (de ziekte van Lhermitte-Duclos)(2011)
Authors: Jan Goffin, Steven De Vleeschouwer
Pages: 612 - 614
Patents
1 - 3 of 3
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)